B
ᣨ2-һᣩǰװÓȮa(chn)DŽ(dng)w(ni)Sx֮һĤ(wn)(jng)fװYȶNܡձֲڲ(dng)MeKXͰ(x)
оl(f)F(xin)ţڶNXpģпܱF(xin)(jng)o(h)ȱѪXкװYţSİ֮һcȺ(qing)Ⱦ(qing)[ţڼίĝӰһ(g)ԽԽP(gun)עI(lng)
ţẬzy(c)ڿƌW(xu)оеđ(yng)
һίоͪʳT(do)đ֭ͨ^pٿ·ՁA(y)
@ƪ}顶Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorptionоУIF18.9Ậzy(c)ԇڶzy(c)СѪеxˮƽD1(yn)CͪʳKDa(b)ʳKDM(du)ѪxẬӰ푣M(jn)ųxẬ׃(du)ţY(ji)đ֭ᣨ TDCATUDCAѭh(hun)ĸɔ_

D1 ѪxˮƽMM(jn)W(xu)؏(f)[1]
(dng)}W(wng)ĤǻѪaSAHίоţͨ^{(dio)(ji)GABAB/AKT/GSK 3β/β-catenin;ppW(wng)Ĥ³Ѫ(jng)ԪF´
@ƪ}顶Taurine attenuates neuronal ferroptosis by regulating GABAB/AKT/GSK3β/β-catenin pathway after subarachnoid hemorrhageоУIF8.101ţẬzy(c)ԇ ڶXҺCSFеоP(gun)Ic(din)֮һо߰l(f)F(xin) SAH XҺеţˮƽ@ڌ(du)սMD2@һY(ji)m(x)оṩR(j)fc SAH (jng)o(h)C(j)P(gun)

װYc IBDίоƤNSD2SFMO錧(do)ϳɣֹcƉ
@ƪ}顶Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruptionоУIF7.9Ậzy(c)ԇڶcƤ(x)IECsͼ(x)ϵеĝ׃D3_J(rn)NSD–H3K36me2–FMO–taurine ͨ·ĴCھScϺͿеҪãIBDίṩ(sh)(yn)(j)

D3 ʹzy(c)ԇУn = 4_Nsd 2Vil-KONsd 2Vil-OEСͬCС(jng)^(jng)^DSS̎ă(ni)ĤλYˮƽ[3]
С۽oԔ(x)Bzy(c)ԇʹ÷
һԇнM
|
M |
Ҏ(gu) |
(ch)l |
|
96 װ |
1 K |
|
|
zy(c)_Һ I |
30mL×3 ƿ |
4 |
|
zy(c)_Һ II |
30mL×1 ƿ |
4 |
|
Ⱦԇ A |
10mL×1 ƿ |
4 |
|
Ⱦԇ B |
0.6mL×1 ƿ |
4 |
|
(bio)(zhn)Ʒ |
1 ƿĩ |
4 |
|
Ĥ |
3 |
|
E
1Ϻԇ(zhn)
Ԃϣø(bio)xsˮҺc^xęC(j)Ӌ(j)r(sh)
ȾϹҺʹǰ0.6mLȾԇB뵽ȾԇAУ
(bio)(zhn)ƷҺ(bio)(zhn)Ʒĩм 1mL sˮܽ⣻ȡ 0.5mL ܽĘ(bio)(zhn)ƷҺ 0.5mL sˮKȞ 10mmol/L
ע⣺ԇеȾ׃|(zh)ʹǰF(xin)F(xin)MhL(zhng)ڃ(ch)档
2ӱ̎
1(x)/(x)ӱ(x)(x)ռxĹxĺȥÿ5×10⁶(g)(x)/(x)ӱм0.75mLzy(c)_ҺIM(jn)г飨20%3g10؏(f)30ΣS0.25mLzy(c)_ҺII10,000×gx10ȡҺD(zhun)xĹдzy(c)
2MӱQȡ0.1gM0.75mL zy(c)_Һ I {40ˮԡ30 0.25mL zy(c)_Һ II10,000×g x 10 ȡҺD(zhun)xĹzy(c)
3Ѫ/Ѫ{ӱֱәzy(c)sˮϡጺzy(c)
3Ϙ
±Ә
|
ԇ |
ӱ |
(bio)(zhn)Ʒ |
հ |
|
ƷҺ |
100μL |
-- |
-- |
|
(bio)(zhn)ƷҺ |
-- |
100μL |
-- |
|
sˮ |
-- |
-- |
100μL |
|
ȾϹҺ |
100μL |
100μL |
100μL |
|
ԇNϷĤװ90 15 s 400nm L(zhng)y(c) |
|||
ע(xing)
1茦(du)ߝȘ(bio)(zhn)ƷM(jn)2Bm(x)ݶϡጣ6-8(g)c(din)ңLƘ(bio)(zhn)
2ͬӱţȲ^(du)δ֪ӱhxׂ(g)ƷM(jn)A(y)(sh)(yn)Դ_zy(c)Y(ji)̎ژ(bio)(zhn)(ni)
4(bio)(zhn)
(bio)(zhn)HڅÿΌ(sh)(yn)һlµĘ(bio)(zhn)

zy(c)0.1 mmol/L - 10 mmol/L
Ҋ}
Q1ԇе96װֻһ(g)?q)?yn)ʹôk
A1ԓԇе96װM(fi)͵ģm(x)(sh)(yn)óҎ(gu)96ø(bio)Ҳُ(gu)I۱ø(bio)壨abs7064
Q2ԇвfмИ(bio)(zhn)йʽґ(yng)ԓxķNӋ(j)㷽ʽ
A2ɷNʽxһNͿʽǺ(jin)㷨h(bio)Ӌ(j)㣬(hu)Ӝ(zhn)_ҪעʹØ(bio)(zhn)ÿΌ(sh)(yn)LƘ(bio)(zhn)
Q3ԇһòL(zhng)ܱ
A3ԇȾ(Dye)ܽ׃|(zh)ҪF(xin)F(xin)h(ch)L(zhng)ڃ(ch)Ӱ@ɫx(sh)M(jn)Ӱ푙zy(c)ӱҪzy(c)hӃ(ch)ӱRy(tng)һzy(c)⣬(ch)r(sh)g^û˞ԭ?q)½Mֲʹc˾(lin)ϵΪ(d)ُ(gu)IԇнM
īI(xin):
[1] Li X, Yang J, Zhou X, et al. Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption. Nat Metab. 2024;6(7):1397-1414.
[2] Liu C, He P, Guo Y, et al. Taurine attenuates neuronal ferroptosis by regulating GABAB/AKT/GSK3β/β-catenin pathway after subarachnoid hemorrhage. Free Radic Biol Med. 2022;193(Pt 2):795-807.
[3]Xu Y, Xiao X, Ma C, et al. Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption. Clin Transl Med. 2024;14(12):e70128.
ڮa(chn)Ʒ]]
|
؛̖(ho)-Ҏ(gu) |
a(chn)ƷQ |
/zy(c) |
|
ţ |
98%BR(j) |
|
|
zy(c)ԇ |
0.1 mmol/L - 10 mmol/L |
xP(gun)ԇ]
|
؛̖(ho)-Ҏ(gu) |
a(chn)ƷQ |
zy(c) |
|
(AA)zy(c)ԇ |
0.03 mmol/L - 3 mmol/L |
|
|
ȱD(zhun)øALTzy(c)ԇ |
0.625μmol/mL-20μmol/mL |
|
|
ȲD(zhun)ø (AST)zy(c)ԇ |
0.625μmol/mL-20μmol/mL |
|
|
Ȱzy(c)ԇ |
0.03 mmol/L - 3 mmol/L |
|
|
Ȱø (GLS)zy(c)ԇ |
0.01 mmol/L - 1 mmol/L |
|
|
uzy(c)ԇ |
2 umol/L - 200 umol/L |
|
|
øzy(c)ԇ |
0.1 mmol/L -3 mmol/L |
|
|
PROzy(c)ԇ |
2 ug/mL - 200 ug/mL |
|
|
װzy(c)ԇ |
20 mmol/L - 2000 mmol/L |
|
|
هzy(c)ԇ |
0.1 mmol/L - 5 mmol/L |
|
|
ɫzy(c)ԇ |
0.05 mmol/L - 10 mmol/L |
|
|
γ-ᣨGABAzy(c)ԇУ |
- |
|
|
ϳø/uøzy(c)ԇ |
0.01 mmol/L - 1 mmol/L |